COVID-19 Relief. The Company Group Members have (i) to the extent applicable, complied in all material respects with applicable Tax Law in order to defer the amount of the employer’s share of any “applicable employment taxes” under Section 2302 of the CARES Act, (ii) not deferred any payroll tax obligations pursuant to any Payroll Tax Executive Order, (iii) to the extent applicable, complied in all material respects with applicable Tax Law regarding Tax credits under Sections 7001 through 7005 of the Families First Act and Section 2301 of the CARES Act, and (iv) not sought (nor has any Affiliate that would be aggregated with any Company Group Member and treated as one employer for purposes of Section 2301 of the CARES Act sought) a covered loan under paragraph (36) of Section 7(a) of the Small Business Act (15 U.S.C. 636(a)), as added by Section 1102 of the CARES Act.
COVID-19 Relief. Section 4.25 of the Company Disclosure Schedule sets forth all loans, subsidies, deferrals or other relief with respect to COVID-19 outstanding at the Company or any Company Subsidiary as of the date hereof (“COVID-19 Relief”). At the time it submitted all documentation with respect to and availed itself of the benefits of each COVID Relief, the Company or applicable Company Subsidiary satisfied all applicable material eligibility requirements related to the receipt of such COVID-19 Relief, and all information submitted with respect thereto was complete and accurate in all material respects. The Company and each Company Subsidiary has continued to comply with the applicable requirements of all COVID-19 Relief, and used any proceeds therefrom for permissible purposes as required by such COVID-19 Relief, in each case in all material respects. To the Company’s knowledge no facts or circumstances exist that would materially impair the ability of the Company or applicable Company Subsidiary to obtain forgiveness of the applicable COVID-19 Relief.
COVID-19 Relief. Except as set forth on Schedule 4.27, neither the Company nor any Subsidiary has obtained any financial aid or other assistance or relief under any Pandemic Response Law. With respect to any assistance or relief set forth on Schedule 4.27, the Company and each Subsidiary (a) has complied in all material respects with the requirements of the applicable program, (b) has utilized all such assistance received by them in accordance with the Pandemic Response Laws and other Laws, including maintaining accounting records or distributing or expending such relief in an unauthorized manner, (c) has not made any misstatement or omission of fact (whether intentional or unintentional) to any Governmental Authority or the lender thereunder, and, (d) if applicable, has submitted forgiveness applications for all outstanding loans or other financial assistance received and forgiveness in full has been granted. All applications, questionnaires, and other material documents related to such COVID-19 financial aid or other assistance was correct and complete at the time of filing, and correct and complete copies have been provided to Purchaser.
COVID-19 Relief. Except as set forth on Schedule 3.24, as of the date hereof, no Acquired Company has applied for or received loans, deferred Taxes (including, but not limited to, payroll Taxes), claimed any Tax credits (including, but not limited to, payroll retention tax credits), or availed itself to any Tax benefits pursuant to the CARES Act and COVID Relief Programs and, in any case, none of the foregoing actions are reasonably anticipated during the applicable Interim Period.
COVID-19 Relief. Tenant will remain eligible for, and will be permitted to receive, any past, present or future financial and other COVID-19 related relief that may be granted to Tenant, or for which Tenant may be eligible, by or from JWA or any other source.
COVID-19 Relief. The Company has not availed itself of any Tax relief pursuant to any Pandemic Response Laws that could reasonably be expected to impact the Tax payment or reporting obligations of the Company after the Closing Date.
COVID-19 Relief. (a) The Borrower and the other Loan Parties hereby certify that (i) this Consent is being entered into as a result of the effects of the national emergency related to COVID-19 pandemic and (ii) as of December 31, 2019, the Borrower was not more than 30 days past due on all payment obligations under the Credit Agreement and the other Loan Documents (including, for the avoidance of doubt, payments of interest, principal and fees required thereunder).
COVID-19 Relief. No Acquired Entity or member of the Seller Group has obtained any financial aid or other assistance or relief under, any federal, state or local programs adopted in response to COVID-19, including the CARES Act, the Enhancement Act, the Federal Reserve Main Street Lending Program and any similar non-US Law or program (collectively, the “COVID-19 Relief Programs”). With respect to any assistance or relief obtained under any COVID-19 Relief Program, the Acquired Entities and the members of the Seller Group have complied in all material respects with the requirements of the applicable program.
COVID-19 Relief. Except as set forth on Schedule 5.26, no member of the Company Group has obtained any material financial aid or other assistance or relief under, any federal, state or local programs adopted in response to COVID-19, including the CARES Act, the Enhancement Act, the Federal Reserve Main Street Lending Program and any similar non-US law or program. With respect to any assistance or relief set forth on Schedule 5.26, the Company Group has complied in all material respects with the requirements of the applicable program.
COVID-19 Relief. Section 4.25 of the Company Disclosure Schedule sets forth all loans, subsidies, deferrals, short-term working allowance or other similar relief with respect to COVID-19 outstanding at the Company or any Company Subsidiary (“COVID-19 Relief”). At the time it submitted all documentation with respect to and availed itself of the benefits of each COVID-19 Relief, the Company or applicable Company Subsidiary satisfied all applicable material eligibility requirements related to the receipt of such COVID-19 Relief, and all information submitted with respect thereto (including to Turkish Employment Agency) was complete and accurate in all material respects. The Company and each Company Subsidiary have continued to comply with the applicable requirements of all COVID-19 Relief, and used any proceeds therefrom for permissible purposes as required by such COVID-19 Relief, in each case in all material respects.
